PharmaBiome
A Swiss biotech company producing live biotherapeutic products to address disturbances of the gut microbiome.
PharmaBiome is a spin-off company of ETH Zurich, and has developed a technology platform for the production of standardized microbiome-based products. The NicheMap is a drug-development platform which includes an in vitro culture based technology enabling the quantitative understanding of the link between microbiome composition and activity.
Latest PharmaBiome News & Features
11 December 2023
27 November 2023
15 December 2014
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze